Guía de Práctica Clínica para el Manejo de Pacientes con Ictus en Atención Primaria.

Versión resumida

V. completa | Info. Pacientes | Consulta rápida

Recomendaciones de la GPC

Preguntas de la GPC

Autoría

Abre nueva ventana: Bibliografía en versión pdf

Descargar Bibliografía

(657 Kb)

Descargar GPC sobre Ictus en AP (res.)

(16,29 Mb)

Bibliografía

1. Grupo de trabajo sobre GPC. Elaboración de Guías de Práctica Clínica en el Sistema Nacional de Salud. Manual Metodológico. Madrid. Plan Nacional para el SNS del MSC. Instituto Aragonés de Ciencias de la salud-I+CS; 2007. Guías de Práctica Clínica en el SNS: I+CS Nº 2006/0I.

2. Grupo de trabajo de la Guía de prevención del ictus. Centro Cochrane Iberoamericano, coordinador. Guía de práctica clínica sobre la prevención primaria y secundaria del ictus. Madrid: Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Consumo. Agència d’Avaluació de Tecnologia i Recerca Mèdiques; 2008. Guía de práctica clínica: AATRM N.º 2006/15.

3. Grupo de trabajo sobre actualización de GPC. Actualización de Guías de Práctica Clínica en el Sistema Nacional de Salud. Manual Metodológico. Madrid: Plan Nacional para el SNS del MSC. Instituto Aragonés de Ciencias de la Salud I+CS; 2008. Guías de Práctica Clínica en el SNS: I+CS Nº 2007/02-01.

4. Estrategia en Ictus del Sistema Nacional de Salud. 2008. Ministerio de Sanidad y Consumo. [Documento Internet]. [Acceso 3 febrero 2009]. Disponible en: http://www.semg.es/doc/documentos_SEMG/estrategias_icuts_SNS.pdf

5. Mackay J, Mensah G, editores. Atlas of heart disease and stroke. Geneva: WHO & CDC; 2004.

6. Mortalidad y morbilidad hospitalaria por enfermedades cardiovasculares. Centro Nacional de Epidemiología. [Documento Internet]. [Acceso 8 septiembre 2008]. Disponible en: http://www.isciii.es/htdocs/centros/epidemiologia/epi_cardiovasculares.jsp

7. Mortalidad por enfermedad cerebrovascular. Tasas anuales ajustadas por edad y específica por sexos. España 1951 - 2002. Centro Nacional de Epidemiología. [Documento Internet]. [Acceso 7 octubre 2008]. Disponible en: http://www.isciii.es/htdocs/centros/epidemiologia/epi_cerebrovascular.jsp

8. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004;363:1925-33.

9. Defunciones según la causa de muerte. INE 2006. [Documento Internet]. [Acceso 8 septiembre 2008]. Disponible en: www.ine.es

10. Encuesta de morbilidad hospitalaria. INE 2006. [Documento Internet]. [Acceso 8 septiembre 2008]. Disponible en: www.ine.es

11. Marrugat J, Arboix A, García-Eroles L, Salas T, Vila J, Castell C, et al. Estimación de la incidencia poblacional y la mortalidad de la enfermedad cerebrovascular establecida isquémica y hemorrágica. Rev Esp Cardiol. 2007;60:573-80.

12. Díaz-Guzmán J, Egido J, Abilleira S, Barberá G, Gabriel R. Incidencia del ictus en España: Datos prelimiares crudos del estudio IBERICTUS. Neurología. 2007;22:605.

13. Truelsen T, Piechowski-Jozwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol 2006;13:581-98.

14. Leno C, Berciano J, Combarros O, Polo JM, Pascual J, Quintana F, et al. A prospective study of stroke in young adults in Cantabria, Spain. Stroke. 1993;24:792-5.

15. Caicoya M, Rodríguez T, Lasheras C, Cuello R, Corrales C, Blazquez B. Incidencia del accidente cerebrovascular en Asturias, 1990-1991. Rev Neurol. 1996;24:806- 11.

16. López-Pousa S, Vilalta J, Llinas J. Prevalencia de la enfermedad vascular cerebral en España. Estudio en un área rural de Girona. Rev Neurol. 1995;23:1081-6.

17. Alzamora MT, Sorribes M, Heras A, Vila N, Vicheto M, Fores R, et al. Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study. BMC Neurol. 2008;8:5.

18. Sempere AP, Duarte J, Cabezas C, Clavería LE. Incidence of transient ischemic attacks and minor ischemic strokes in Segovia, Spain. Stroke. 1996;27:667-71.

19. Matías-Guiu J, Oltra A, Falip R, Martín R, Galiano L. Occurrence of transient ischemic attacks in Alcoi: descriptive epidemiology. Neuroepidemiology. 1994;13:34-9.

20. Díaz-Guzman J, Bermejo-Pareja F, Benito-León J, Vega S, Gabriel R, Medrano MJ. Prevalence of stroke and transient ischemic attack in three elderly populations of central Spain. Neuroepidemiology. 2008;30:247-53.

21. Boix R, del Barrio JL, Saz P, Rene R, Manubens JM, Lobo A, et al. Stroke prevalence among the Spanish elderly: an analysis based on screening surveys. BMC Neurol. 2006;6:36.

22. Durán MA. Informe sobre el impacto social de los enfermos dependientes por ictus (Informe ISEDIC, 2004). Madrid: Editorial Luzón; 2004.

23. Mathers CD, Stein C, Fath DM, Murray CJL, López AD. Global Burden of Disease 2000: version 2, methods and results. Discussion paper nº 50. World Health Organization. Geneva, 2002. [Documento Internet]. [Acceso 8 septiembre 2008]. Disponible en: http://www.who.int/healthinfo/paper50.pdf

24. Bergman L, van der Meulen J, Limburg M, Habbena DF. Costs of medical care after first-ever stroke in the Netherlands. Stroke. 1995;26:1830-6.

25. Isard P, Forbes J. The cost of stroke to the National Health Service in Scotland. Cerebrovasc Dis. 1992;2:47-50.

26. Alvarez Sabín J, Alonso de Leciñana M, Gallego J, Gil Peralta A, Casado I, Castillo J, et al. Plan de atención sanitaria al ictus. Neurología. 2006;21:717-26.

27. Beguiristain JM, Mar J, Arrazola A. El coste de las enfermedades neurológicas. Rev Neurol. 2005;40:406-11.

28. Carod FJ, Egido JA, González JL, Varela de Seijas E. Coste directo de la enfermedad cerebrovascular en el primer año de seguimiento. Rev Neurol. 1999;28:1123-30.

29. Medina Rodríguez A, López Bastida J, Serrano Aguilar P, Montón Álvarez F, Gutiérrez Moreno S. Análisis socioeconómico de los supervivientes de ictus. Rev Neurol. 2004;19:549.

30. Rossnagel K, Jungehulsing GJ, Nolte CH, Muller-Nordhorn J, Roll S, Wegscheider K, et al. Out-of-hospital delays in patients with acute stroke. Ann Emerg Med. 2004;44:476-83.

31. Castilla Guerra L, Fernández Moreno MC, López Chozas JM. Tratamiento del paciente con ictus agudo en un área rural. Papel de la atención primaria. Rev Neurol. 2004;38:997-8.

32. Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P. Factors influencing early admission in a French stroke unit. Stroke;33:153-9.

33. Harraf F, Sharma AK, Brown MM, Lees KR, Vass RI, Kalra L. A multicentre observational study of presentation and early assessment of acute stroke. BMJ. 2002;325:17.

34. Morales Ortíz A, Amorín M, Fages EM, Moreno Escribano A, Villaverde González R, Martínez Navarro ML, et al. Utilización del sistema de emergencias extrahospitalario en el tratamiento del ictus agudo en la región de Murcia. Posible repercusión en la asistencia sanitaria urgente del ictus. Rev Neurol. 2006;42:68-72.

35. Conde Sendín MA, Aladro Y, Amela Peris R. Análisis de la demora prehospitalaria en la asistencia al ictus. Rev Neurol. 2005;41:321-6.

36. Dávalos A, Castillo J, Martínez Vila E. Delay in neurological attention and stroke outcome. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. Stroke. 1995;26:2233-7.

37. Castilla Guerra L, Fernández Moreno MC, Balbuena García M, López Chozas JM, Jiménez Hernández MD. Conocimiento sobre el tratamiento de la hipertensión, hiperglucemia y antiagregación en la fase aguda del ictus por los médicos de atención primaria. Rev Neurol. 2007;45:511.

38. Gibbs RG, Newson R, Lawrenson R, Greenhalgh RM, Davies AH. Diagnosis and initial management of stroke and transient ischemic attack across UK health regions from 1992 to 1996: experience of a national primary care database. Stroke. 2001;32:1085-90.

39. Plan Director de la Enfermedad Vascular Cerebral del Departamento de Salud de la Generalitat de Catalunya. Ictus: Guía de Práctica Clínica. 2ª edición. Barcelona: Agencia de Evaluación de Tecnología e Investigación Médicas, 2007.

40. Hare R, Rogers H, Lester H, McManus R, Mant J. What do stroke patients and their carers want from community services? Fam Pract. 2006;23:131-6.

41. Murray J, Ashworth R, Forster A, Young J. Developing a primary care-based stroke service: a review of the qualitative literature. Br J Gen Pract. 2003;53:137-42.

42. Brotheridge S, Young J, Dowswell G, Lawler J, Forster A. A preliminary investigation of patient and carer expectations of their general practitioner in longer-term stroke care. J Eval Clin Pract. 1998;4:237-41.

43. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke. 1990;21:637-76.

44. Alvarez Sabín J. Patología cerebrovascular. En: Rodés J, Carné X, Trilla A, editores. Manual de Terapeútica Médica.Barcelona: Editorial Masson; 2002. p. 527-41.

45. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, et al. Transient ischemic attack--proposal for a new definition. N Engl J Med. 2002;347:1713-6.

46. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40:2276-93.

47. Díez Tejedor E, Del Bruto O, Alvarez Sabín J, Muñoz M, Abiusi G. Clasificación de las enfermedades cerebrovasculares. Sociedad Iberoamericana de Enfermedades Cerebrovasculares. Rev Neurol. 2001;33:455-64.

48. Kidwell CS, Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol. 2008;7:256-67.

49. Arboix A, Pérez Sempere A, Alvarez Sabín J. Ictus: tipos etiológicos y criterios diagnósticos. En: Díez Tejedor E, editor. Guía para el diagnóstico y tratamiento del ictus. Barcelona: Prous Science; 2006: 1-23.

50. Comité Internacional de Clasificación de la WONCA. Clasificación Internacional de la Atención Primaria: CIAP-2. Barcelona: Masson. 1999.

51. International Statistical Classification of Diseases and Related Health Problems. 10th Revision. World Health Organization. 2007. [Documento Internet]. [Acceso 3 febrero 2009]. Disponible en: http://www.who.int/classifications/apps/icd/icd10online/

52. Ministerio de Sanidad y Consumo. Clasificación internacional de enfermedades 9ª revisión, modificación clínica (CIE 9-MC). 5ª Edición. Madrid: Ministerio de Sanidad y Consumo. 2006.

53. Know Stroke. Know the Signs. Act in Time. NINDS. January 2008. NIH Publication No. 08-4872. National Institute of Neurological Disorders and Stroke. [Documento Internet]. [Acceso 9 diciembre 2008]. Disponible en: http://www.ninds.nih.gov/disorders/stroke/stroke.htm

54. Do you think you are having a stroke? National Stroke Foundation, 2007. [Documento Internet]. [Acceso 9 diciembre 2008]. Disponible en: http://www.strokefoundation.com.au/are-you-are-having-a-stroke

55. El ictus ¿Qué es, cómo se previene y trata? Grupo de Estudio de Enfermedades Cerebrovasculares de la Sociedad Española de Neurología, 2000. [Documento Internet]. [Acceso 9 diciembre 2008]. Disponible en: http://www.ictussen.org/files3/El_ictus_que_es_como_previr&tratar.pdf

56. Goldstein LB, Simel DL. Is this patient having a stroke? JAMA. 2005;293:2391- 402.

57. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58:113-30.

58. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke. 1988;19:1083-92.

59. Herman B, Leyten AC, van Luijk JH, Frenken CW, Op de Coul AA, Schulte BP. Epidemiology of stroke in Tilburg, the Netherlands. The population-based stroke incidence register: 2. Incidence, initial clinical picture and medical care, and three-week case fatality. Stroke. 1982;13:629-34.

60. Barrett KM, Brott TG, Brown RD, Jr., Frankel MR, Worrall BB, Silliman SL, et al. Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke. J Stroke Cerebrovasc Dis. 2007;16:34-9.

61. Adams HP, Jr., del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115:e478-e534.

62. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604-7.

63. Bonita R, Beaglehole R. Modification of Rankin Scale: Recovery of motor function after stroke. Stroke. 1988;19:1497-500.

64. García Pais MJ, Rigueiro Veloso MT, Portero Vázquez A, Rivas Bande MJ, Martínez Vázquez F, Casariego Vales E. Ictus, una guía para médicos. Fisterra. [Documento Internet]. [Acceso 9 enero 2009]. Disponible en: http://www.fisterra.com/guias2/ictus.asp

65. Hand PJ, Kwan J, Lindley RI, Dennis MS, Wardlaw JM. Distinguishing between stroke and mimic at the bedside: the brain attack study. Stroke. 2006;37:769-75.

66. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke. 2000;31:71-6.

67. Norris JW, Hachinski VC. Misdiagnosis of stroke. Lancet. 1982;1:328-31.

68. Libman RB, Wirkowski E, Alvir J, Rao TH. Conditions that mimic stroke in the emergency department. Implications for acute stroke trials. Arch Neurol. 1995;52:1119-22.

69. Kothari R, Barsan W, Brott T, Broderick J, Ashbrock S. Frequency and accuracy of prehospital diagnosis of acute stroke. Stroke. 1995;26:937-41.

70. Jensen K, Tfelt-Hansen P, Lauritzen M, Olesen J. Classic migraine. A prospective recording of symptoms. Acta Neurol Scand. 1986;73:359-62.

71. National Collaborating Centre for Chronic Conditions. Stroke: National Clinical Guideline for diagnosis and initial management of acute stroke and transient ischaemic attack (TIA). NICE clinical guideline 68. London. 2008. [Documento Internet]. [Acceso 5 septiembre 2008]. Disponible en: http://www.nice.org.uk

72. Malouf R, Brust JC. Hypoglycemia: causes, neurological manifestations, and outcome. Ann Neurol. 1985;17:421-30.

73. Healton EB, Brust JC, Feinfeld DA, Thomson GE. Hypertensive encephalopathy and the neurologic manifestations of malignant hypertension. Neurology. 1982;32:127-32.

74. Vroomen PC, Buddingh MK, Luijckx GJ, De Keyser J. The incidence of stroke mimics among stroke department admissions in relation to age group. J Stroke Cerebrovasc Dis. 2008;17:418-22.

75. Hemphil JC III, Chung SS. Factitious stroke presenting for acute treatment. J Stroke Cerebrovasc Dis. 1999;8:88-90.

76. Snyder H, Robinson K, Shah D, Brennan R, Handrigan M. Signs and symptoms of patients with brain tumors presenting to the emergency department. J Emerg Med. 1993;11:253-8.

77. Moster ML, Johnston DE, Reinmuth OM. Chronic subdural hematoma with transient neurological deficits: a review of 15 cases. Ann Neurol. 1983;14:539-42.

78. National Stroke Foundation. Clinical Guidelines for Acute Stroke Management. Melbourne: NSF. 2007. [Documento Internet]. [Acceso 5 septiembre 2008]. Disponible en: http://www.strokefoundation.com.au/news/welcome/clinical-guidelines-for-acutestroke-management

79. Scottish Intercollegiate Guidelines Network. Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention (SIGN Guideline 108). Edinburgh. [Documento Internet]. [Acceso 20 enero 2009]. Disponible en: http://www.sign.ac.uk/pdf/sign108.pdf

80. Harbison J, Hossain O, Jenkinson D, Davis J, Louw SJ, Ford GA. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke. 2003;34:71-6.

81. Nor AM, McAllister C, Louw SJ, Dyker AG, Davis M, Jenkinson D, et al. Agreement between ambulance paramedic- and physician-recorded neurological signs with Face Arm Speech Test (FAST) in acute stroke patients. Stroke. 2004;35:1355-9.

82. Kothari RU, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med. 1999;33:373-8.

83. Hurwitz AS, Brice JH, Overby BA, Evenson KR. Directed use of the Cincinnati Prehospital Stroke Scale by laypersons. Prehosp Emerg Care. 2005;9:292-6.

84. Bray JE, Martin J, Cooper G, Barger B, Bernard S, Bladin C. Paramedic identification of stroke: community validation of the melbourne ambulance stroke screen. Cerebrovasc Dis. 2005;20:28-33.

85. Bray JE, Martin J, Cooper G, Barger B, Bernard S, Bladin C. An interventional study to improve paramedic diagnosis of stroke. Prehosp Emerg Care. 2005;9:297-302.

86. Nor AM, Davis J, Sen B, Shipsey D, Louw SJ, Dyker AG, et al. The Recognition of Stroke in the Emergency Room (ROSIER) scale: development and validation of a stroke recognition instrument. Lancet Neurol. 2005;4:727-34.

87. Schroeder EB, Rosamond WD, Morris DL, Evenson KR, Hinn AR. Determinants of use of emergency medical services in a population with stroke symptoms: the Second Delay in Accessing Stroke Healthcare (DASH II) Study. Stroke. 2000;31:2591-6.

88. Morris DL, Rosamond W, Madden K, Schultz C, Hamilton S. Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke. 2000;31:2585-90.

89. Wester P, Radberg J, Lundgren B, Peltonen M. Factors associated with delayed admission to hospital and in-hospital delays in acute stroke and TIA: a prospective, multicenter study. Seek Medical-Attention-in-Time Study Group. Stroke. 1999;30:40-8.

90. Kwan J, Hand P, Sandercock P. Improving the efficiency of delivery of thrombolysis for acute stroke: a systematic review. QJM. 2004;97:273-9.

91. Silverman IE, Beland DK, Chhabra J, McCullough LD. The "drip-and-ship" ap-proach: starting IV t-PA for acute ischemic stroke at outside hospitals prior to transfer to a regional stroke center. Conn Med. 2005;69:613-20.

92. Rymer MM, Thurtchley D, Summers D. Expanded modes of tissue plasminogen activator delivery in a comprehensive stroke center increases regional acute stroke interventions. Stroke. 2003;34:e58-e60.

93. Grupo de trabajo Asociación Madrileña de Neurología y Servicio Madrileño de Salud. Atención a los pacientes con ictus en la Comunidad de Madrid. Consejería de Sanidad, 2009. [Documento Internet]. [Acceso 6 abril 2009]. Disponible en: http://www.madrid.org/cs/Satellite?c=CM_Publicaciones_FA&cid=1142553237007& idConsejeria=1109266187266&idListConsj=1109265444710&language=es&pagenam e=ComunidadMadrid%2FEstructura&pid=1109265444699&sm=1109265844004

94. Alvarez Sabín J, Molina C, Abilleira S, Montaner J, García F, Alijotas J. "Código Ictus" y tiempos de latencia en el tratamiento de reperfusión durante la fase aguda del ictus isquémico. Med Clin (Barc). 1999;113:481-3.

95. Alvarez Sabín J, Molina CA, Abilleira S, Montaner J, García A, Jiménez X, et al. Impacto de la activación del Código Ictus en la eficacia del tratamiento trombolítico. Med Clin (Barc). 2003;120:47-51.

96. Zarza B, de Leciñana MA, García-Barragán N, Díaz-Sánchez M, López-Sendon JL, Cruz-Culebras A, et al. Influencia de la curva de aprendizaje y del código ictus extrahospitalario en el tratamiento trombolítico del ictus agudo. Neurología. 2008;23:349-55.

97. Belvis R, Cocho D, Martí Fabregas J, Pagonabarraga J, Aleu A, García Bargo MD, et al. Benefits of a prehospital stroke code system. Feasibility and efficacy in the first year of clinical practice in Barcelona, Spain. Cerebrovasc Dis. 2005;19:96-101.

98. Kjellstrom T, Norrving B, Shatchkute A. Helsingborg Declaration 2006 on European stroke strategies. Cerebrovasc Dis. 2007;23:231-41.

99. Langhorne P, Pollock A. What are the components of effective stroke unit care? Age Ageing. 2002;31:365-71.

100. Gilligan AK, Thrift AG, Sturm JW, Dewey HM, Macdonell RA, Donnan GA. Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit? Cerebrovasc Dis. 2005;20:239-44.

101. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit). care for stroke. Cochrane Database Syst Rev 2001;(3):CD000197.

102. Ronning OM, Guldvog B. Stroke unit versus general medical wards, II: neurological deficits and activities of daily living: a quasi-randomized controlled trial. Stroke. 1998;29:586-90.

103. Ronning OM, Guldvog B. Stroke units versus general medical wards, I: twelve- and eighteen-month survival: a randomized, controlled trial. Stroke. 1998;29:58-62.

104. Rudd AG, Hoffman A, Irwin P, Pearson M, Lowe D. Stroke units: research and reality. Results from the National Sentinel Audit of Stroke. Qual Saf Health Care. 2005;14:7-12.

105. Indredavik B. Stroke units - the Norwegian experience. Cerebrovasc Dis. 2003;15 Suppl 1:19-20.

106. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL. Stroke unit treatment. 10-year follow-up. Stroke. 1999;30:1524-7.

107. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL. Stroke unit treatment improves long-term quality of life: a randomized controlled trial. Stroke. 1998;29:895-9.

108. Indredavik B, Slordahl SA, Bakke F, Rokseth R, Haheim LL. Stroke unit treatment. Long-term effects. Stroke. 1997;28:1861-6.

109. Indredavik B, Bakke F, Solberg R, Rokseth R, Haaheim LL, Holme I. Benefit of a stroke unit: a randomized controlled trial. Stroke. 1991;22:1026-31.

110. Foley N, Salter K, Teasell R. Specialized stroke services: a meta-analysis comparing three models of care. Cerebrovasc Dis. 2007;23:194-202.

111. Evans A, Pérez I, Harraf F, Melbourn A, Steadman J, Donaldson N, et al. Can differences in management processes explain different outcomes between stroke unit and stroke-team care? Lancet. 2001;358:1586-92.

112. Koton S, Schwammenthal Y, Merzeliak O, Philips T, Tsabari R, Bruk B, et al. Effectiveness of establishing a dedicated acute stroke unit in routine clinical practice in Israel. Isr Med Assoc J. 2005;7:688-93.

113. Ronning OM, Guldvog B, Stavem K. The benefit of an acute stroke unit in patients with intracranial haemorrhage: a controlled trial. J Neurol Neurosurg Psychiatry. 2001;70:631-4.

114. Reid J, MacLeod MJ, Williams D. Timing of aspirin and secondary preventative therapies in acute stroke: support for use of stroke units. Scott Med J. 2005;50:69- 72.

115. Stroke Unit Trialists' Collaboration . Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD000197. DOI: 10.1002/14651858.CD000197.pub2.

116. Stavem K, Ronning OM. Quality of life 6 months after acute stroke: impact of initial treatment in a stroke unit and general medical wards. Cerebrovasc Dis. 2007;23:417-23.

117. Patel A, Knapp M, Pérez I, Evans A, Kalra L. Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial. Stroke. 2004;35:196-203.

118. Saka O, Serra V, Samyshkin Y, McGuire A, Wolfe CC. Cost-effectiveness of stroke unit care followed by early supported discharge. Stroke. 2009;40:24-9.

119. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33:1315-20.

120. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet. 1997;349:1641-9.

121. Castillo J, Leira R, García MM, Serena J, Blanco M, Dávalos A. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke. 2004;35:520-6.

122. Blood pressure in Acute Stroke Collaboration (BASC).Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Systematic Reviews 2001;(3):CD000039.

123. Horn J, Limburg M. Calcium antagonists for ischemic stroke: a systematic review. Stroke. 2001;32:570-6.

124. Bath PMW, Willmot MM, Leonardi-Bee J, Bath-Hextall FJ. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD000398. DOI: 10.1002/14651858. CD000398.

125. Gray LJ, Sprigg N, Rashid PA, Willmot MR, Bath PM. Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke. J Stroke Cerebrovasc Dis. 2006;15:245-9.

126. The Blood Pressure in Acute Stroke Collaboration . Vasoactive drugs for acute stroke. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD002839. DOI: 10.1002/14651858.CD002839.

127. Geeganage C, Bath PMW. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD000039. DOI: 10.1002/14651858.CD000039.pub2.

128. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009;8:48-56.

129. Eames PJ, Robinson TG, Panerai RB, Potter JF. Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period. Cerebrovasc Dis. 2005;19:253-9.

130. Ahmed N, Nasman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke. 2000;31:1250-5.

131. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-7.

132. Kaplan NM. Management of hypertensive emergencies. Lancet. 1994;344:1335-8.

133. Armario P, Tovar JL, Sierra P, Rubio F, Alvarez-Sabín J. Manejo de las alteraciones de la presión arterial en la fase aguda del ictus. Actualización 2008 del Documento de Consenso de las Sociedades Catalanas de Hipertensión y de Neurología. Hipertensión. 2008;25:255-62.

134. Bath P, Chalmers J, Powers W, Beilin L, Davis S, Lenfant C, et al. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens. 2003;21:665-72.

135. Martinsson L, Wahlgren NG. Safety of dexamphetamine in acute ischemic stroke: a randomized, double-blind, controlled dose-escalation trial. Stroke. 2003;34:475-81.

136. Hillis AE, Ulatowski JA, Barker PB, Torbey M, Ziai W, Beauchamp NJ, et al. A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis. 2003;16:236-46.

137. Allport L, Baird T, Butcher K, Macgregor L, Prosser J, Colman P, et al. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care. 2006;29:1839-44.

138. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology. 1982;32:1239-46.

139. Dietrich WD, Alonso O, Busto R. Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke. 1993;24:111-6.

140. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-32.

141. Bruno A, Biller J, Adams HP, Jr., Clarke WR, Woolson RF, Williams LS, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999;52:280-4.

142. Passero S, Ciacci G, Ulivelli M. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology. 2003;61:1351-6.

143. Fuentes B, Castillo J, San José B, Leira R, Serena J, Vivancos J, et al. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study. Stroke. 2009;40:562-8.

144. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2004;164:2005- 11.

145. Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 2007;6:397-406.

146. Vinychuk SM, Melnyk VS, Margitich VM. Hyperglycemia after acute ischemic stroke: Prediction, significance and immediate control with insulin-potassium-saline-magnesium infusions. Heart Drug. 2005;5:197-204.

147. Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med. 2006;13:174-80.

148. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002;59:669-74.

149. Lindsberg PJ, Soinne L, Roine RO, Salonen O, Tatlisumak T, Kallela M, et al. Community- based thrombolytic therapy of acute ischemic stroke in Helsinki. Stroke. 2003;34:1443-9.

150. Alvarez Sabín J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribó M, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-- treated patients. Stroke. 2003;34:1235-41.

151. Alvarez Sabín J, Molina CA, Ribó M, Arenillas JF, Montaner J, Huertas R, et al. Impact of admission hyperglycemia on stroke outcome after thrombolysis: risk stratification in relation to time to reperfusion. Stroke. 2004;35:2493-8.

152. Leigh R, Zaidat OO, Suri MF, Lynch G, Sundararajan S, Sunshine JL, et al. Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke. 2004;35:1903-7.

153. Rowat AM, Dennis MS, Wardlaw JM. Hypoxaemia in acute stroke is frequent and worsens outcome. Cerebrovasc Dis. 2006;21:166-72.

154. O'Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use in adult patients. Thorax. 2008;63 Suppl 6:vi1-68.

155. Ingvar DH, Lassen NA. Treatment of focal cerebral ischemia with hyperbaric oxygen. Report of 4 cases. Acta Neurol Scand. 1965;41:92-5.

156. Singhal AB, Dijkhuizen RM, Rosen BR, Lo EH. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology. 2002;58:945-52.

157. Kim HY, Singhal AB, Lo EH. Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol. 2005;57:571-5.

158. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159-63.

159. Singhal AB, Benner T, Roccatagliata L, Koroshetz WJ, Schaefer PW, Lo EH, et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005;36:797-802.

160. De La Morandiere KP, Walter D. Oxygen therapy in acute stroke. Emerg Med J. 2003;20:547.

161. Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke. 1999;30:2033-7.

162. Sandercock PAG, Counsell C, Gubitz GJ, Tseng MC. Antiplatelet therapy for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD000029. DOI: 10.1002/14651858.CD000029.pub2.

163. Chen ZM, Sandercock P, Pan HC, Counsell C, Collins R, Liu LS, et al. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups. Stroke. 2000;31:1240-9.

164. Bhalla A, Sankaralingam S, Dundas R, Swaminathan R, Wolfe CD, Rudd AG. Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke. 2000;31:2043-8.

165. Asplund K. Haemodilution for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD000103. DOI: 10.1002/14651858.CD000103.

166. Wu CM, McLaughlin K, Lorenzetti DL, Hill MD, Manns BJ, Ghali WA. Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med. 2007;167:2417-22.

167. Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007;6:1063-72.

168. Lavallee PC, Meseguer E, Abboud H, Cabrejo L, Olivot JM, Simon O, et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007;6:953-60.

169. Rothwell PM, Giles MF, Chandratheva A, Marquardt L, Geraghty O, Redgrave JN, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet. 2007;370:1432-42.

170. Luengo Fernández R, Gray AM, Rothwell PM. Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison. Lancet Neurol 2009;8:235-43.

171. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284:2901-6.

172. Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005;366:29-36.

173. Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369:283-92.

174. Chandratheva A, Mehta Z, Geraghty OC, Marquardt L, Rothwell PM. Populationbased study of risk and predictors of stroke in the first few hours after a TIA. Neurology. 2009;72:1941-7.

175. Koton S, Rothwell PM. Performance of the ABCD and ABCD2 scores in TIA patients with carotid stenosis and atrial fibrillation. Cerebrovasc Dis. 2007;24:231-5.

176. Tsivgoulis G, Vassilopoulou S, Spengos K. Potential applicability of ABCD score in triaging TIA patients. Lancet. 2007;369:1082.

177. Bray JE, Coughlan K, Bladin C. Can the ABCD Score be dichotomised to identify high-risk patients with transient ischaemic attack in the emergency department? Emerg Med J. 2007;24:92-5.

178. Cucchiara BL, Messe SR, Taylor RA, Pacelli J, Maus D, Shah Q, et al. Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack? Stroke. 2006;37:1710-4.

179. Purroy GF, Molina CA, Montaner VJ, Delgado MP, Santamarina PE, Toledo M, et al. Ausencia de utilidad de la escala clínica ABCD en el riesgo de infarto cerebral precoz en pacientes con accidente isquémico transitorio. Med Clin (Barc). 2007;128:201-3.

180. Purroy F, Montaner J, Molina CA, Delgado P, Ribó M, Álvarez-Sabín J. Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke. 2007;38:3225-9.

181. Purroy F, Begué R, Quílez A, Pinol-Ripoll G, Sanahuja J, Brieva L, et al. Implicaciones diagnósticas del perfil de recurrencia tras un ataque isquémico transitorio. Med Clin (Barc). 2009;133:283-9.

182. Sheehan OC, Merwick A, Kelly LA, Hannon N, Marnane M, Kyne L, et al. Diagnostic Usefulness of the ABCD2 Score to Distinguish Transient Ischemic Attack and Minor Ischemic Stroke From Noncerebrovascular Events. The North Dublin TIA Study. Stroke. 2009;40:3449-3454.

183. Cifu DX, Stewart DG. Factors affecting functional outcome after stroke: a critical review of rehabilitation interventions. Arch Phys Med Rehabil. 1999;80:S35-S39.

184. Musicco M, Emberti L, Nappi G, Caltagirone C. Early and long-term outcome of rehabilitation in stroke patients: the role of patient characteristics, time of initiation, and duration of interventions. Arch Phys Med Rehabil. 2003;84:551-8.

185. Scottish Intercollegiate Guidelines Network. Management of patients with stroke: Assessment, Rehabilitation, Prevention and Management of Complications, and Discharge Planning, (SIGN Guideline 64). Edinburgh. 2002. [Documento Internet]. [Acceso 20 enero 2009]. Disponible en: http://www.sign.ac.uk/pdf/sign64.pdf

186. Veterans Health Administration, Department of Defense. VA/DoD clinical practice guideline for the management of stroke rehabilitation in the primary care setting. Washington (DC): Department of Veterans Affairs. 2003.

187. Outpatient Service Trialists. Therapy-based rehabilitation services for stroke patients at home. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD002925. DOI: 10.1002/14651858.CD002925.

188. Teasell R, Bayona N, Bitensky J. Background Concepts in Stroke Rehabilitation. Evidence- Based Review of Stroke Rehabilitation, 2008. [Documento Internet]. [Acceso 1 junio 2009]. Disponible en: www.ebrsr.com

189. Intercollegiate Stroke Working Party. National clinical guideline for stroke, 3rd edition. London: Royal College of Physicians. 2008.

190. Kimura M, Murata Y, Shimoda K, Robinson RG. Sexual dysfunction following stroke. Compr Psychiatry. 2001;42:217-22.

191. Otegbayo JA, Talabi OA, Akere A, Owolabi MO, Owolabi LF, Oguntoye OO. Gastrointestinal complications in stroke survivors. Trop Gastroenterol. 2006;27:127- 30.

192. Lesniak M, Bak T, Czepiel W, Seniow J, Czlonkowska A. Frequency and prognostic value of cognitive disorders in stroke patients. Dement Geriatr Cogn Disord. 2008;26:356-63.

193. Christensen D, Johnsen SP, Watt T, Harder I, Kirkevold M, Andersen G. Dimensions of post-stroke fatigue: a two-year follow-up study. Cerebrovasc Dis. 2008;26:134-41.

194. Engelter ST, Gostynski M, Papa S, Frei M, Born C, Ajdacic-Gross V, et al. Epidemiology of aphasia attributable to first ischemic stroke: incidence, severity, fluency, etiology, and thrombolysis. Stroke. 2006;37:1379-84.

195. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, et al. Medical complications after stroke: a multicenter study. Stroke. 2000;31:1223-9.

196. Leppavuori A, Pohjasvaara T, Vataja R, Kaste M, Erkinjuntti T. Generalized anxiety disorders three to four months after ischemic stroke. Cerebrovasc Dis. 2003;16:257-64.

197. Sackley C, Brittle N, Patel S, Ellins J, Scott M, Wright C, et al. The prevalence of joint contractures, pressure sores, painful shoulder, other pain, falls, and depression in the year after a severely disabling stroke. Stroke. 2008;39:3329-34.

198. Van Ouwenwaller C, Laplace PM, Chantraine A. Painful shoulder in hemiplegia. Arch Phys Med Rehabil. 1986;67:23-6.

199. Watkins CL, Leathley MJ, Gregson JM, Moore AP, Smith TL, Sharma AK. Prevalence of spasticity post stroke. Clin Rehabil. 2002;16:515-22.

200. Teasell R, Foley N, Salter K, Bhogal S. Medical complications poststroke. Evidence-Based Review of Stroke Rehabilitation, 2008. [Documento Internet]. [Acceso 20 abril 2009]. Disponible en: www.ebrsr.com

201. Teasell R, Foley N, Bhogal S. Painful Hemiplegic Shoulder. Evidence-Based Review of Stroke Rehabilitation, 2008. [Documento Internet]. [Acceso 20 abril 2009]. Disponible en: www.ebrsr.com

202. Teasell R, Foley N, Martino R, Bhogal S, Speechley M. Dysphagia and Aspiration post Stroke. Evidence-Based Review of Stroke Rehabilitation, 2008. [Documento Internet]. [Acceso 13 abril 2009]. Disponible en: www.ebrsr.com

203 Barer DH. The natural history and functional consequences of dysphagia after hemispheric stroke. J Neurol Neurosurg Psychiatry. 1989;52:236-41.

204. Forster A, Young J. Incidence and consequences of falls due to stroke: a systematic inquiry. BMJ. 1995;311:83-6.

205. National Stroke Foundation. Clinical Guideline for Stroke Rehabilitation and Recovery. Melbourne: NSF. 2005. [Documento Internet]. [Acceso 13 octubre 2008]. Disponible en: http://www.nhmrc.gov.au/publications/synopses/_files/cp105.pdf

206. Sommerfeld DK, Eek EU, Svensson AK, Holmqvist LW, von Arbin MH. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke.2004;35:134-9.

207. Satkunam LE. Rehabilitation medicine: 3. Management of adult spasticity. CMAJ. 2003;169:1173-9.

208. Lundstrom E, Terent A, Borg J. Prevalence of disabling spasticity 1 year after firstever stroke. Eur J Neurol. 2008;15:533-9.

209. Montane E, Vallano A, Laporte JR. Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review. Neurology. 2004 ;63:1357-63.

210. Simpson DM, Gracies JM, Yablon SA, Barbano R, Brashear A. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study. J Neurol Neurosurg Psychiatry. 2009;80:380-5.

211. Foley N, Teasell R, Bhogal S. Mobility and the Lower Extremity. Evidence-Based Review of Stroke Rehabilitation, 2008. [Documento Internet]. [Acceso 4 mayo 2009]. Disponible en: www.ebrsr.com

212. Foley N, Teasell R, Jutai J, Bhogal S, kruger E. Upper Extremity Interventions. Evidence- Based Review of Stroke Rehabilitation, 2008. [Documento Internet]. [Acceso 4 mayo 2009]. Disponible en: www.ebrsr.com

213. Goldstein LB. Common drugs may influence motor recovery after stroke. The Sygen In Acute Stroke Study Investigators. Neurology. 1995;45:865-71.

214. Troisi E, Paolucci S, Silvestrini M, Matteis M, Vernieri F, Grasso MG, et al. Prognostic factors in stroke rehabilitation: the possible role of pharmacological treatment. Acta Neurol Scand. 2002;105:100-6.

215. Ward A, Roberts G, Warner J, Gillard S. Cost-effectiveness of botulinum toxin type a in the treatment of post-stroke spasticity. J Rehabil Med. 2005;37:252-7.

216. Teasell R, Foley N, Salter K, Bhogal S. Botulinum Toxin in the Treatment of Upper and lower Limb Spasticity Post Stroke. Evidence-Based Review of Stroke Rehabilitation, 2008. [Documento Internet]. [Acceso 4 mayo 2009]. Disponible en: www. ebrsr.com

217. Wissel J, Ward AB, Erztgaard P, Bensmail D, Hecht MJ, Lejeune TM, et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med. 2009;41:13-25

218. Creedon SD, Dijkers MP, Hinderer SR. Intrathecal baclofen for severe spasticity: a meta-analysis. Int J Rehab Health. 1997;3:171-85.

219. Wanklyn P, Forster A, Young J. Hemiplegic shoulder pain (HSP): natural history and investigation of associated features. Disabil Rehabil 1996;18:501.

220. Carr EK, Kenney FD. Positioning of the stroke patient: a review of the literature. Int J Nurs Stud. 1992;29:355-69.

221. Ada L, Foongchomcheay A, Canning CG. Supportive devices for preventing and treating subluxation of the shoulder after stroke. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD003863. DOI: 10.1002/14651858.CD003863.pub2.

222. Griffin A, Bernhardt J. Strapping the hemiplegic shoulder prevents development of pain during rehabilitation: a randomized controlled trial. Clin Rehabil. 2006;20:287-95.

223. Inaba MK, Piorkowski M. Ultrasound in treatment of painful shoulders in patients with hemiplegia. Phys Ther. 1972;52:737-42.

224. Linn SL, Granat MH, Lees KR. Prevention of shoulder subluxation after stroke with electrical stimulation. Stroke. 1999;30:963-8.

225. Chantraine A, Baribeault A, Uebelhart D, Gremion G. Shoulder pain and dysfunction in hemiplegia: effects of functional electrical stimulation. Arch Phys Med Rehabil. 1999;80:328-31.

226. Hanger HC, Whitewood P, Brown G, Ball MC, Harper J, Cox R, et al. A randomized controlled trial of strapping to prevent post-stroke shoulder pain. Clin Rehabil. 2000;14:370-80.

227. Faghri PD, Rodgers MM, Glaser RM, Bors JG, Ho C, Akuthota P. The effects of functional electrical stimulation on shoulder subluxation, arm function recovery, and shoulder pain in hemiplegic stroke patients. Arch Phys Med Rehabil. 1994;75:73-9.

228. Price CIM, Pandyan AD. Electrical stimulation for preventing and treating poststroke shoulder pain. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD001698. DOI: 10.1002/14651858.CD001698.

229. Snels IA, Dekker JH, van der Lee JH, Lankhorst GJ, Beckerman H, Bouter LM. Treating patients with hemiplegic shoulder pain. Am J Phys Med Rehabil. 2002;81:150-60.

230. Leandri M, Parodi CI, Corrieri N, Rigardo S. Comparison of TENS treatments in hemiplegic shoulder pain. Scand J Rehabil Med. 1990;22:69-71.

231. Partridge CJ, Edwards SM, Mee R, van Langenberghe H. Hemiplegic shoulder pain: a study of two methods of physiotherapy treatment. Clin Rehabil. 1990;4:43-9.

232. Poduri KR. Shoulder pain in stroke patients and its effects on rehabilitation. J Stroke Cerebrovasc Dis. 1993;3:261-6.

233. Andersen G, Vestergaad K, Ingerman-Nielsen M, Jensen TS. Incidence of central post-stroke pain. Pain. 1995;61:187-93.

234. Hansson P. Post-stroke pain case study: clinical characteristics, therapeutic options and long-term follow-up. Eur J Neurol. 2004;11 (Suppl 1):22-30.

235. Leijon G, Boivie J. Central post-stroke pain. A controlled trial of amitriptyline and carbamazepine. Pain. 1989;36:27-36.

236. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD005454. DOI: 10.1002/14651858.CD005454. pub2.

237. Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD005451. DOI: 10.1002/14651858.CD005451.

238. Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD006044. DOI: 10.1002/14651858.CD006044. pub2.

239. Vranken JH, Dijkgraaf MGW, Kruis MR, van der Vegt MH, Hollmann MW, Heesen M. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain. 2008;136:150-7.

240. A 13-Week Randomized, Multi-Center, Double-Blind, Placebo-Controlled, Parallel- Group Study to Evaluate the Efficacy, Safety and Tolerability of Pregabalin (150-600 mg/day) Using a Flexible Dosing Schedule in the Treatment of Subjects with Central Post-Stroke Pain (CPSP)Protocol No: A0081063. NCT00313820. [Documento Internet]. [Acceso 4 noviembre 2009]. Disponible en: http://www.clinicalstudyresults.org/documents/company-study_9523_0.pdf

241. Iranami H, Yamazaki A, Hatano Y. Tramadol challenge for relief of intractable central poststroke pain. Mayo Clin Proc. 2006;81:566.

242. Takahashi Y, Hashimoto K, Tsuji S. Successful use of zonisamide for central poststroke pain. J Pain. 2004;5:192-4.

243. Ramritu P, Finlayson K, Mitchell A, Croft G. Identification and Nursing Management of Dysphagia in Individuals with Neurological Impairment. Joanna Briggs Institute for Evidence Based Nursing and Midwifery; 2000. Systematic Review No. 8.

244. Scottish Intercollegiate Guidelines Network. Management of patients with stroke: identification and management of dysphagia, (SIGN Guideline 78). Edinburgh. 2004. [Documento Internet]. [Acceso 20 enero 2009]. Disponible en: http://www.sign.ac.uk/pdf/sign78.pdf

245. Heart and Stroke Foundation of Ontario. Improving Recognition and management of Dysphagia in Acute Stroke. 2002. [Documento Internet]. [Acceso 13 abril 2009]. Disponible en: http://profed.heartandstroke.ca/ClientImages/1/Dysphagia%20Booklet%20FINAL%2020050203.pdf

246. Finestone HM, Greene-Finestone LS, Wilson ES, Teasell RW. Malnutrition in stroke patients on the rehabilitation service and at follow-up: prevalence and predictors. Arch Phys Med Rehabil. 1995;76:310-6.

247. Garon BR, Engle M, Ormiston C. A randomized control trial to determine the effects of unlimited oral intake of water in patients with identified aspiration. J Neurol Rehabil. 1997;11:139-48.

248. Groher ME. Bolus management and aspiration pneumonia in patients with pseudobulbar dysphagia. Dysphagia. 1987;1:215-6.

249. O'Mahony D, McIntyre AS. Artificial feeding for elderly patients after stroke. Age Ageing. 1995;24:533-5.

250. Bath PMW, Bath-Hextall FJ, Smithard D. Interventions for dysphagia in acute stroke. Cochrane Database of Systematic Reviews 1999, Issue 4. Art. No.: CD000323. DOI: 10.1002/14651858.CD000323.

251. Miller RE, Castlemain B, Lacqua FJ, Kotler DP. Percutaneous endoscopic gastrostomy. Results in 316 patients and review of literature. Surg Endosc. 1989;3:186- 90.

252. Larson DE, Burton DD, Schroeder KW, DiMagno EP. Percutaneous endoscopic gastrostomy. Indications, success, complications, and mortality in 314 consecutive patients. Gastroenterology. 1987;93:48-52.

253. Finucane TE, Bynum JP. Use of tube feeding to prevent aspiration pneumonia. Lancet. 1996;348:1421-4.

254. Dennis M, Lewis S, Cranswick G, Forbes J. FOOD: a multicentre randomised trial evaluating feeding policies in patients admitted to hospital with a recent stroke. Health Technol Assess. 2006;10.

255. Park RH, Allison MC, Lang J, Spence E, Morris AJ, Danesh BJ, et al. Randomised comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding in patients with persisting neurological dysphagia. BMJ. 1992;304:1406-9.

256. Dwolatzky T, Berezovski S, Friedmann R, Paz J, Clarfield AM, Stessman J, et al. A prospective comparison of the use of nasogastric and percutaneous endoscopic gastrostomy tubes for long-term enteral feeding in older people. Clin Nutr. 2001;20:535-40.

257. Yates JS, Lai SM, Duncan PW, Studenski S. Falls in community-dwelling stroke survivors: an accumulated impairments model. J Rehabil Res Dev. 2002;39:385- 94.

258. Hyndman D, Ashburn A, Stack E. Fall events among people with stroke living in the community: circumstances of falls and characteristics of fallers. Arch Phys Med Rehabil. 2002;83:165-70.

259. Jorgensen L, Engstad T, Jacobsen BK. Higher incidence of falls in long-term stroke survivors than in population controls: depressive symptoms predict falls after stroke. Stroke. 2002;33:542-7.

260. Teasell R, McRae M, Foley N, Bhardwaj A. The incidence and consequences of falls in stroke patients during inpatient rehabilitation: factors associated with high risk. Arch Phys Med Rehabil. 2002;83:329-33.

261. Gillespie LD, Robertson MC, Gillespie WJ, Lamb SE, Gates S, Cumming RG, Rowe BH. Interventions for preventing falls in older people living in the comunity. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007146. DOI: 10.1002/14651858. CD007146.pub2.

262. Cheng PT, Wang CM, Chung CY, Chen CL. Effects of visual feedback rhythmic weight- shift training on hemiplegic stroke patients. Clin Rehabil. 2004;18:747-53.

263. Cheng PT, Wu SH, Liaw MY, Wong AM, Tang FT. Symmetrical body-weight distribution training in stroke patients and its effect on fall prevention. Arch Phys Med Rehabil. 2001;82:1650-4.

264. Green J, Forster A, Bogle S, Young J. Physiotherapy for patients with mobility problems more than 1 year after stroke: a randomised controlled trial. Lancet. 2002;359:199-203.

265. Parker MJ, Gillespie WJ, Gillespie LD. Hip protectors for preventing hip fractures in older people. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD001255. DOI: 10.1002/14651858.CD001255.pub3.

266. Batchelor FA, Hill KD, Mackintosh SF, Said CM, Whitehead CH. The FLASSH study: protocol for a randomised controlled trial evaluating falls prevention after stroke and two sub-studies. BMC Neurol. 2009;9:14.

267. Hackett ML, Yapa C, Parag V, Anderson CS. Frequency of depression after stroke: a systematic review of observational studies. Stroke. 2005;36:1330-40.

268. Ouimet MA, Primeau F, Cole MG. Psychosocial risk factors in poststroke depression: a systematic review. Can J Psychiatry. 2001;46:819-28.

269. Carota A, Berney A, Aybek S, Iaria G, Staub F, Ghika-Schmid F, et al. A prospective study of predictors of poststroke depression. Neurology. 2005;64:428-33.

270. Storor DL, Byrne GJ. Pre-morbid personality and depression following stroke. Int Psychogeriatr. 2006;18:457-69.

271. Salter K, Bhogal S, Teasell R, Foley N, Speechley M. Post Stroke Depression. Evidence- Based Review of Stroke Rehabilitation, 2008. [Documento Internet]. [Acceso 4 mayo 2009]. Disponible en: www.ebrsr.com

272. Paolucci S, Gandolfo C, Provinciali L, Torta R, Sommacal S, Toso V. Quantification of the risk of post stroke depression: the Italian multicenter observational study DESTRO. Acta Psychiatr Scand. 2005;112:272-8.

273. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003689. DOI: 10.1002/14651858.CD003689.pub3.

274. Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA. 2008;299:2391-400.

275. Narushima K, Kosier JT, Robinson RG. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis. 2002;190:296-303.

276. Ebrahim S, Barer D, Nouri F. Affective illness after stroke. Br J Psychiatry. 1987;151:52-6.

277. House A, Dennis M, Hawton K, Warlow C. Methods of identifying mood disorders in stroke patients: experience in the Oxfordshire Community Stroke Project. Age Ageing. 1989;18:371-9.

278. Salter K, Bhogal S, Foley N, Jutai J, Teasell R. The assessment of poststroke depression. Top Stroke Rehabil. 2007;14:1-24.

279. Watkins CL, Lightbody CE, Sutton CJ, Holcroft L, Jack CI, Dickinson HA, et al. Evaluation of a single-item screening tool for depression after stroke: a cohort study. Clin Rehabil. 2007;21:846-52.

280. Bennett HE, Thomas SA, Austen R, Morris AM, Lincoln NB. Validation of screening measures for assessing mood in stroke patients. Br J Clin Psychol. 2006;45:367-76.

281. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD003437. DOI: 10.1002/14651858.CD003437.pub3.

282. Kimura M, Tateno A, Robinson RG. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials. Am J Geriatr Psychiatry. 2003;11:320-7.

283. House A, Hackett ML, Anderson CS, Horrocks JA. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD003690. DOI: 10.1002/14651858.CD003690.pub2.

284. Choi-Kwon S, Han SW, Kwon SU, Kang DW, Choi JM, Kim JS. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a doubleblind, placebo-controlled study. Stroke. 2006;37:156-61.

285. Roman GC, Sachdev P, Royall DR, Bullock RA, Orgogozo JM, López-Pousa S, et al. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci. 2004;226:81-7.

286. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), American Psychiatric Association, Washington, DC. 1994.

287. Ingles JL, Wentzel C, Fisk JD, Rockwood K. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke. 2002;33:1999-2002.

288. Patel M, Coshall C, Rudd AG, Wolfe CD. Natural history of cognitive impairment after stroke and factors associated with its recovery. Clin Rehabil. 2003;17:158-66.

289. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke. 1997;28:785-92.

290. Mok VC, Wong A, Lam WW, Fan YH, Tang WK, Kwok T, et al. Cognitive impairment and functional outcome after stroke associated with small vessel disease. J Neurol Neurosurg Psychiatry. 2004;75:560-6.

291. Linden T, Skoog I, Fagerberg B, Steen B, Blomstrand C. Cognitive impairment and dementia 20 months after stroke. Neuroepidemiology. 2004;23:45-52.

292. Salter K, Teasell R, Bitensky J, Foley N, Bhogal S. Cognitive Disorders and Apraxia. Evidence-Based Review of Stroke Rehabilitation, 2008. [Documento Internet]. [Acceso 17 junio 2009]. Disponible en: www.ebrsr.com

293. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.

294. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence- based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133-42.

295. Scottish Intercollegiate Guidelines Network. Management of patients with Dementia. A National Clinical Guideline (SIGN Guideline 86). Edinburgh. 2006. [Documento Internet]. [Acceso 20 enero 2009]. Disponible en: http://www.sign.ac.uk/pdf/sign86.pdf

296. National Collaborating Centre for Mental Health. Dementia: supporting people with dementia and their carers in health and social care. NICE clinical guideline 42. London. 2006. [Documento Internet]. [Acceso 7 enero 2009]. Disponible en: http://www.nice.org.uk

297. Sohlberg MM, Mateer CA. Introduction to cognitive rehabilitation. New York: Guildford Press; 1989.

298. Cicerone KD, Dahlberg C, Kalmar K, Langenbahn DM, Malec JF, Bergquist TF, et al. Evidence-based cognitive rehabilitation: recommendations for clinical practice. Arch Phys Med Rehabil. 2000;81:1596-615.

299. Cicerone KD, Dahlberg C, Malec JF, Langenbahn DM, Felicetti T, Kneipp S, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Arch Phys Med Rehabil. 2005;86:1681-92.

300. Clare L, Woods B. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD003260. DOI: 10.1002/14651858.CD003260.

301. das Nair R, Lincoln N. Cognitive rehabilitation for memory deficits following stroke. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD002293. DOI: 10.1002/14651858.CD002293.pub2.

302. Lincoln N, Majid M, Weyman N. Cognitive rehabilitation for attention deficits following stroke. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD002842. DOI: 10.1002/14651858.CD002842.

303. Bowen A, Lincoln N. Cognitive rehabilitation for spatial neglect following stroke. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD003586. DOI: 10.1002/14651858.CD003586.pub2.

304. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61-5.

305. Baztán JJ, Pérez del Molino J, Alarcón T, San Cristóbal E, Izquierdo G, Manzarbeitia I. Índice de Barthel: Instrumento válido para la valoración funcional de pacientes con enfermedad cerebrovascular. Rev Esp Geriatr Gerontol. 1993;28:32-40.

306. Guide for the Uniform Data Set for Medical Rehabilitation (Adult FIM), Version 4.0. Buffalo, NY 14214: State University of New York at Buffalo. 1993.

307. Legg L, Drummond A, Langhorne P. Occupational therapy for patients with problems in activities of daily living after stroke. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD003585. DOI: 10.1002/14651858.CD003585.pub2.

308. Walker MF, Leonardi-Bee J, Bath P, Langhorne P, Dewey M, Corr S, et al. Individual patient data meta-analysis of randomized controlled trials of community occupational therapy for stroke patients. Stroke. 2004;35:2226-32.

309. Salter K, Teasell R, Bhogal S, Foley N. Community Reintegration. Evidence-Based Review of Stroke Rehabilitation, 2008. [Documento Internet]. [Acceso 17 junio 2009]. Disponible en: www.ebrsr.com

310. Dirección General de Tráfico. Patología Médica y Conducción de vehículos. Guía para el consejo médico. Madrid: Dirección General de Tráfico. 2002.

311. Real Decreto 818/2009, de 8 de mayo, por el que se aprueba el Reglamento General de Conductores. BOE núm. 138, 8 de junio de 2009.

312. Muller JE. Sexual activity as a trigger for cardiovascular events: what is the risk?. Am J Cardiol. 1999;84:2N-5N.

313. Davey SG, Frankel S, Yarnell J. Sex and death: are they related? Findings from the Caerphilly Cohort Study. BMJ. 1997;315:1641-4.

314. Agencia Española de Medicamentos y Productos Sanitarios. AEMPS 2009. [Documento Internet]. [Acceso 1 junio 2009]. Disponible en: https://www.agemed.es/

315. Herdman TH, Heath C, Meyer G, Scroggins L, Vasallo B. Diagnósticos Enfermeros: definiciones y clasificación 2007-2008. NANDA Internacional. Madrid: Elsevier. 2008.

316. Moorhead S, Johnson M, Maas M. Clasificación de resultados de Enfermería (NOC). 3ª ed. Madrid. Elsevier España. 2005.

317. McCloskey Dochterman J, Bulechek G. Clasificación de Intervenciones de enfermería (NIC). 4ª ed. Madrid: Elsevier España. 2005. 318. O'Mahony PG, Rodgers H, Thomson RG, Dobson R, James OF. Satisfaction with information and advice received by stroke patients. Clin Rehabil. 1997;11:68-72.

319. Rodgers H, Bond S, Curless R. Inadequacies in the provision of information to stroke patients and their families. Age Ageing. 2001;30:129-33.

320. Clark MS. Patient and spouse perceptions of stroke and its rehabilitation. Int J Rehabil Res. 2000;23:19-29.

321. Wellwood I, Dennis MS, Warlow CP. Perceptions and knowledge of stroke among surviving patients with stroke and their carers. Age Ageing. 1994;23:293-8.

322. Drummond A, Lincoln N, Juby L. Effects of a stroke unit on knowledge of stroke and experiences in hospital. Health Trends. 1996;28:26-30.

323. Smith J, Forster A, Young J. Cochrane review: information provision for stroke patients and their caregivers. Clin Rehabil. 2009;23:195-206.

324. Ayana M, Pound P, Lampe F, Ebrahim S. Improving stroke patients' care: a patient held record is not enough. BMC. Health Serv Res. 2001;1:1.

325. Hoffmann T, McKenna, K. Worrall L, Read, SJ. Evaluating current practice in the provision of written information to stroke patients and their carers. International Journal of Therapy and Rehabilitation. 2004;11:303-10.

326. Wachters-Kaufmann C, Schuling J, The H, Meyboom-de JB. Actual and desired information provision after a stroke. Patient Educ Couns. 2005;56:211-7.

327. Scottish Intercollegiate Guidelines Network. A guideline developer's handbook (SIGN Guideline 50). Edinburgh. 2008. [Documento Internet]. [Acceso 7 enero 2009]. Disponible en: http://www.sign.ac.uk/guidelines/fulltext/50/index.html

328. National Institute for Health and Clinical Excellence (April 2007. The guidelines manual. London: National Institute for Health and Clinical Excellence. [Documento Internet]. [Acceso 7 enero 2009]. Disponible en: http://www.nice.org.uk

Última actualización: julio 2010